Indian D2C skincare brand Be Clinical just secured a ₹21 Crore seed extension. Beyond the capital injection itself, this deal highlights a clear shift in how Indian beauty brands operate: white-label outsourcing is ou...
Indian D2C skincare brand Be Clinical just secured a ₹21 Crore seed extension. Beyond the capital injection itself, this deal highlights a clear shift in how Indian beauty brands operate: white-label outsourcing is out, and in-house R&D is in. With digital customer acquisition costs (CAC) soaring across performance marketing channels, off-the-shelf formulations can no longer deliver the gross margins or repeat purchase rates required to build a sustainable business. To build long-term enterprise value today, scaling evidence-based skincare brands must own their proprietary IP, engineer active delivery platforms in-house, and handle regulatory compliance under their own roof.
Verifiable dermatological outcomes require precise formulation mechanics, not just clever marketing copy. Bringing formulation science inside the house allows brands to engineer active delivery systems with surgical precision:
Encapsulated Retinoids: Polymer and lipid micro-encapsulation of Hydroxypinacolone Retinoate (HPR) and Retinol ensures controlled, sustained active release. This mechanism significantly cuts trans-epidermal water loss (TEWL) and erythema while optimizing nuclear retinoic acid receptor (RAR) binding to boost collagen synthesis.
Stabilised L-Ascorbic Acid Systems: Formulating pure L-Ascorbic Acid requires aqueous stabilization at a strict pH below 3.5, backed by Ferulic Acid and Vitamin E. This system neutralises reactive oxygen species (ROS) singlet oxygen radicals and blocks tyrosinase activity while preventing formula oxidation in the container.
Biomimetic Lipid Matrix: Emulsions engineered with lamellar-phase Ceramides NP, AP, and EOP—alongside targeted biomimetic peptides—directly repair the intercellular lipid structure of the stratum corneum.
Operating a full-stack clinical facility also reshapes how brands navigate regulatory compliance under India’s CDSCO Cosmetics Rules, 2020.
Objective Efficacy Verification: Badging products as "clinically proven" or "dermatologist tested" demands GCP-compliant human volunteer trials. Brands cannot rely on raw ingredient supplier data sheets. Efficacy must be quantified using objective biophysical diagnostics, including Corneometers for skin hydration metrics and Mexameters for melanin quantification.
Classification Boundaries: Formulations must operate strictly within Chapter IV of the Drugs & Cosmetics Act. Product claims cannot imply permanent physiological alterations, which risks reclassification as a pharmaceutical drug—a complex regulatory hurdle for D2C brands.
Stability & Safety Testing: Running an internal facility requires ICH Q1A-compliant accelerated stability profiling alongside Bureau of Indian Standards (BIS) testing to cap heavy metals like Lead at or below 20 ppm and guarantee strict microbial limits.
Beyond IP ownership, full-stack manufacturing fundamentally reshapes the balance sheet. Bringing R&D and production in-house delivers an immediate 15% to 25% gross margin expansion. Eliminating third-party contract markups on proprietary active premixes creates an essential cushion to absorb CAC spikes across digital channels.
This shift puts traditional Contract Development and Manufacturing Organisations (CDMOs) in a tight spot. To keep clinical D2C clients, contract manufacturers can no longer act as simple toll processors. They must evolve into turnkey partners offering proprietary IP co-development, in-house High-Performance Liquid Chromatography (HPLC) assay validation, and pre-compiled clinical dossiers. Be Clinical's funding round makes one thing clear: long-term market leadership belongs to brands that treat formulation science as their core strategic asset.
Formulating high-payload, ethanol-free fine fragrances usually forces a compromise between thermodynamic stability and skin-feel. Drop ethanol from a formula, and chemists typically face a grim choice: accept cloudy e...
In the Indian dermocosmetics sector, biomimetic peptides are among the highest-value active ingredients in anti-aging formulation. Synthetic sequences like Copper Tripeptide-1, Palmitoyl Pentapeptide-4, and Acetyl Hex...
